As well as opening its new Dublin biotech facility, the pharma company has recently begun construction on an expansion at its Carlow site. MSD Ireland is today (1 November) officially opening its new ...

Pharmaceutical giant MSD - part of the US group Merck - has been given the go-ahead for plans to build a new biologics facility in Swords, Co Dublin, that will employ 350. MSD has said that number ...

Pharma group MSD has announced plans for a new biotech facility in Dublin in a move that is expected to create 350 jobs. The plant will be built on the site of its former women's healthcare product ...

MSD Ireland's new manufacturing facility at MSD Biotech in Swords, Co Dublin, has been officially opened Taoiseach, Micheál Martin and Robert M. Davis, Global CEO and President of MSD. The healthcare ...

550 jobs are to be created in Dublin by pharmaceutical company MSD and design software firm Autodesk. 350 of the new jobs will be provided by MSD at a new manufacturing facility in north Dublin. The ...

MSD Ireland is to open a new facility in Swords under the MSD Biotech banner, which is set to create 350 jobs on the same site as the plant the company shut down last year. The company's former plant ...

John Kennedy is a journalist who served as editor of Silicon Republic for 17 years. His interests include all things technological, music, movies, reading, history, gaming and losing the occasional ...

Pharma giant Merck Sharp Dohme in Leopardstown is set to hire more workers, writes GORDON SMITH OFFICIALLY OPENED last week, the Dublin shared services facility of pharma giant Merck Sharp Dohme (MSD) ...

Support from readers like you keeps The Journal open. You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to ...

Pharmaceutical giant MSD is to create 350 jobs at a biotechnology facility in Dublin, in an indication that protectionist policies from US President Donald Trump have not impacted Ireland’s foreign ...

Pharmaceutical giant Merck, which operates as MSD outside of the U.S., is to acquire the WuXi Vaccines manufacturing plant in Dundalk as part of a €500M deal, bringing the U.S.-based company’s ...